Evaluation of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron-loaded patients

Ann N Y Acad Sci. 1990:612:369-77. doi: 10.1111/j.1749-6632.1990.tb24324.x.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Deferiprone
  • Deferoxamine / therapeutic use
  • Humans
  • Iron / blood*
  • Iron Chelating Agents
  • Pyridones / administration & dosage
  • Pyridones / therapeutic use*
  • Thalassemia / blood
  • Thalassemia / therapy*
  • Transfusion Reaction*

Substances

  • Iron Chelating Agents
  • Pyridones
  • Deferiprone
  • Iron
  • Deferoxamine